BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9662018)

  • 1. Flow cytometric analysis of cell cycle fractions in oral leukoplakia.
    Saito T; Mizuno S; Notani K; Fukuda H; Kobayashi I; Shindoh M; Kohgo T
    Int J Oral Maxillofac Surg; 1998 Jun; 27(3):217-21. PubMed ID: 9662018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric analysis of nuclear DNA content in oral leukoplakia: relation to clinicopathologic findings.
    Saito T; Yamashita T; Notani K; Fukuda H; Mizuno S; Shindoh M; Amemiya A
    Int J Oral Maxillofac Surg; 1995 Feb; 24(1 Pt 1):44-7. PubMed ID: 7782640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric analysis of nuclear DNA content in oral leukoplakia.
    Seoane J; Bascones A; Asenjo JA; García-Pola M; Varela-Centelles PI
    Clin Otolaryngol Allied Sci; 1998 Apr; 23(2):136-40. PubMed ID: 9597283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA analysis of oral leukoplakia by flow cytometry.
    Saito T; Notani K; Miura H; Fukuda H; Mizuno S; Shindoh M; Amemiya A
    Int J Oral Maxillofac Surg; 1991 Oct; 20(5):259-63. PubMed ID: 1761874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral cancer genesis and progression: DNA near-diploid aneuploidization and endoreduplication by high resolution flow cytometry.
    Donadini A; Maffei M; Cavallero A; Pentenero M; Malacarne D; Di Nallo E; Truini M; Navone R; Mereu P; Scala M; Santelli A; Gandolfo S; Giaretti W
    Cell Oncol; 2010; 32(5-6):373-83. PubMed ID: 20448331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of resection and aneuploidy on mortality in oral leukoplakia.
    Sudbø J; Lippman SM; Lee JJ; Mao L; Kildal W; Sudbø A; Sagen S; Bryne M; El-Naggar A; Risberg B; Evensen JF; Reith A
    N Engl J Med; 2004 Apr; 350(14):1405-13. PubMed ID: 15070790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA ploidy measurement in oral leukoplakia: different results between flow and image cytometry.
    Brouns ER; Bloemena E; Belien JA; Broeckaert MA; Aartman IH; van der Waal I
    Oral Oncol; 2012 Jul; 48(7):636-40. PubMed ID: 22342568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA cytometry of oral leukoplakia and oral lichen planus.
    Femiano F; Scully C
    Med Oral Patol Oral Cir Bucal; 2005 Apr; 10 Suppl 1():E9-14. PubMed ID: 15800471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA content as a prognostic marker in patients with oral leukoplakia.
    Sudbø J; Kildal W; Risberg B; Koppang HS; Danielsen HE; Reith A
    N Engl J Med; 2001 Apr; 344(17):1270-8. PubMed ID: 11320386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of DNA ploidy status in patients with oral leukoplakia.
    Bremmer JF; Brakenhoff RH; Broeckaert MA; Beliën JA; Leemans CR; Bloemena E; van der Waal I; Braakhuis BJ
    Oral Oncol; 2011 Oct; 47(10):956-60. PubMed ID: 21880540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-ploidy rates in oral leukoplakias determined by flow-cytometry.
    Grässel-Pietrusky R; Deinlein E; Hornstein OP
    J Oral Pathol; 1982 Dec; 11(6):434-8. PubMed ID: 6819351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferative verrucous leukoplakia. Four cases with flow cytometric analysis.
    Kahn MA; Dockter ME; Hermann-Petrin JM
    Oral Surg Oral Med Oral Pathol; 1994 Oct; 78(4):469-75. PubMed ID: 7800379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between dysplasia and ploidy status in oral leukoplakia.
    van Zyl AW; van Heerden MB; Langenegger E; van Heerden WF
    Head Neck Pathol; 2012 Sep; 6(3):322-7. PubMed ID: 22430773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Implications of DNA Repair, Ploidy and Telomerase in the Malignant Transformation Risk Assessment of Leukoplakia.
    Thomas G; Tr S; George S P; Somanathan T; Sarojam S; Krishnankutti N; Sreedharan H; Ankathil R
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):309-316. PubMed ID: 32102504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Field effect in oral precancer as assessed by DNA flow cytometry and array-CGH.
    Pentenero M; Donadini A; Di Nallo E; Maffei M; Marino R; Familiari U; Castagnola P; Gandolfo S; Giaretti W
    J Oral Pathol Med; 2012 Feb; 41(2):119-23. PubMed ID: 21950471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing flow cytometric analysis and nucleolar organizer region enumeration in archival oral premalignant lesions.
    Kahn MA; Mincer HH; Dockter ME; Hermann-Petrin JM
    J Oral Pathol Med; 1993 Jul; 22(6):257-62. PubMed ID: 8355224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric analysis of primary and metastatic squamous cell carcinomas of the oral and maxillofacial region.
    Suzuki K; Chen RB; Nomura T; Nakajima T
    J Oral Maxillofac Surg; 1994 Aug; 52(8):855-61; discussion 861-2. PubMed ID: 8040741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The white lesion that kills--aneuploid dysplastic oral leukoplakia.
    Greenspan D; Jordan RC
    N Engl J Med; 2004 Apr; 350(14):1382-4. PubMed ID: 15070786
    [No Abstract]   [Full Text] [Related]  

  • 19. Flow cytometric DNA-ploidy as a prognostic indicator in oral squamous cell carcinoma.
    Wang XL; Chen RM; Wang ZS; Chen WL; Zuo LF
    Chin Med J (Engl); 1990 Jul; 103(7):572-5. PubMed ID: 2119974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S-phase fraction and DNA ploidy in oral leukoplakia.
    Khanna R; Agarwal A; Khanna S; Basu S; Khanna AK
    ANZ J Surg; 2010; 80(7-8):548-51. PubMed ID: 20795971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.